Delivery Order SPE2DE21D0017-SPE2D626F6399

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $14,448 delivery order by the Defense Logistics Agency Medical Supply Chain on October 29, 2025, with performance completion targeted for November 5, 2025. This fixed-price delivery order with economic price adjustment provisions is for ID NOW Strep rapid diagnostic tests, leveraging the company's established expertise in point-of-care testing devices and molecular diagnostic platforms. The award carries no set-aside designation and reflects full and open competition, consistent with Abbott's positioning as a primary federal supplier of diagnostic testing solutions. Performance will be conducted in Lockhart, Florida, where Abbott Rapid DX maintains its principal operations facility.

This delivery order represents a routine procurement action under the Defense Logistics Agency's existing indefinite delivery vehicle structure with Abbott Rapid DX, which has demonstrated sustained performance across hundreds of prior awards ranging from approximately $600 to $69,600. The company's federal contract portfolio emphasizes rapid diagnostic testing supplies and molecular diagnostic equipment, with particular strength in streptococcus and influenza detection capabilities through its ID NOW platform. The modest ceiling value and accelerated completion timeline indicate this is a focused procurement of consumable diagnostic supplies to support Defense Logistics Agency Medical Supply Chain operations and downstream federal healthcare requirements, consistent with the agency's mission to optimize medical readiness across the Department of Defense and affiliated federal healthcare systems.